MyBlueDotsOdyssey Therapeutics Appoints Jason Haas as Chief Financial Officer MyBlueDots4 months ago01 mins BOSTON–(BUSINESS WIRE)–Odyssey Therapeutics, Inc. today announced the appointment of Jason Haas, MBA, as chief financial officer (CFO). Post navigation Previous: GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 PatientsNext: Pet Honesty® Named Official Multivitamin Supplement of the American Kennel Club
Age-related genetic changes in the blood associated with poor cancer prognosis MyBlueDots2 days ago 0
TRIM63 identified as key gene in common heart disease, unlocking potential for earlier diagnosis MyBlueDots2 days ago 0
Newly discovered cells in connective tissue open up strategy against pancreatic cancer MyBlueDots2 days ago 0